–
Alto Neuroscience, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−9.08
FY22:
−27.5
FY23:
−37.8
FY24:
−68.6
FY25:
−66.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−8.83
FY22:
−27.0
FY23:
−35.1
FY24:
−59.6
FY25:
−59.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−9.19
FY22:
−27.7
FY23:
−36.3
FY24:
−61.4
FY25:
−63.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−9.19
FY22:
−27.7
FY23:
−36.3
FY24:
−61.4
FY25:
−63.2
All amounts in millions USD FY21, FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far.